Search Results - "Burmeister, Bryan"

Author Index.

Source: Diseases of the Esophagus. Sep2018, Vol. 31 Issue 13, p1-11. 11p.

Malignant Broncho-Oesophageal Fistula following Radiotherapy for Noninvasive T3 Oesophageal Squamous Cell Carcinoma.

Authors: Reading, Dwayne Burmeister, Bryan

Source: Case Reports in Gastroenterology. 2022, Vol. 16 Issue 2, p333-338. 6p.

Development of the Melanoma Concerns Questionnaire (MCQ-28); refinement of the EORTC QLQ-MEL38 module.

Authors: Winstanley, Julie White, Edward Saw, Robyn et al.

Source: Psycho-Oncology. Feb2020, Vol. 29 Issue 2, p321-330. 10p. 3 Charts, 1 Graph.

Subjects: Melanoma, Rasch models, Principal components analysis, Goodness-of-fit tests

Geographic Terms: Serbia

Evaluation of the clinical outcomes and patient satisfaction related to the use of internal eye shields for electron external beam radiation therapy.

Authors: Tait, Kirsty Burgess, Sinead Burmeister, Elizabeth A. et al.

Source: Journal of Medical Radiation Sciences. Dec2024, Vol. 71 Issue 4, p555-563. 9p.

FA03.05: NEOADJUVANT CHEMOTHERAPY OR CHEMORADIOTHERAPY FOR ADENOCARCINOMA OF THE ESOPHAGUS.

Authors: Visser, Els Edholm, David Smithers, Mark et al.

Source: Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus / I.S.D.E Sep2018; Vol. 31 (13).

Journal Info: Publisher: Oxford University Press / USA ISSN: 1120-8694

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors' reply

Authors: Burmeister, Bryan H Smithers, B Mark

Source: Lancet Oncology. Nov2005, Vol. 6 Issue 11, p825-826. 2p.

Neurotropic Melanoma: The Management of Localised Disease.

Authors: Croker, Jeremy Burmeister, Bryan Foote, Matthew

Source: Journal of Skin Cancer. 2012, p1-6. 6p. 2 Color Photographs, 1 Black and White Photograph.

Adjuvant nodal irradiation in melanoma – Authors' reply

Authors: Burmeister, Bryan Henderson, Michael Thompson, John

Source: Lancet Oncology. Aug2012, Vol. 13 Issue 8, pe327-e327. 1p.

Utility of 30-day mortality as a quality metric for palliative radiation treatment: A population-based analysis from Queensland, Australia.

Authors: Guan, Tracey L. Kutzko, Justin H. Lunn, Dominic P. et al.

Source: Journal of Medical Imaging & Radiation Oncology. Apr2024, Vol. 68 Issue 3, p316-324. 9p.

2012 Reviewer List.

Source: Journal of Medical Imaging & Radiation Oncology. Dec2012, Vol. 56 Issue 6, p714-716. 3p.

Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice.

Authors: Fogarty, Gerald B. Hong, Angela Gondi, Vinai et al.

Source: BMC Cancer. 7/1/2016, Vol. 16, p11-15. 5p. 2 Charts.

Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment – “Hypo Trial” Authors letter of reply

Authors: Porceddu, Sandro V. Rosser, Brenda Burmeister, Bryan et al.

Source: Radiotherapy & Oncology. May2008, Vol. 87 Issue 2, p309-309. 1p.

First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality.

Authors: Fogarty, Gerald B. Hong, Angela Dolven-Jacobsen, Kari et al.

Source: BMC Research Notes. 2015, Vol. 8 Issue 1, p1-6. 6p. 1 Diagram, 4 Charts, 1 Graph.

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.

Authors: Fogarty, Gerald B. Angela Hong Jacobsen, Kari Dolven et al.

Source: BMC Research Notes. 2014, Vol. 7 Issue 1, p2-16. 15p. 6 Charts, 2 Graphs.

The ENHANCES study—Enhancing Head and Neck Cancer patients’ Experiences of Survivorship: study protocol for a randomized controlled trial.

Authors: Turner, Jane Yates, Patsy Kenny, Lizbeth et al.

Source: Trials. 2014, Vol. 15 Issue 1, p1-18. 18p. 2 Charts.

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial.

Authors: Fogarty, Gerald Morton, Rachael L. Vardy, Janette et al.

Source: BMC Cancer. 2011, Vol. 11 Issue 1, p142-149. 8p.

A novel ATM-dependent checkpoint defect distinct from loss of function mutation promotes genomic instability in melanoma.

Authors: Spoerri, Loredana Brooks, Kelly Chia, KeeMing et al.

Source: Pigment Cell & Melanoma Research. May2016, Vol. 29 Issue 3, p329-339. 12p.

Inter- and intra-fraction motion in stereotactic body radiotherapy for spinal and paraspinal tumours using cone-beam CT and positional correction in six degrees of freedom.

Authors: Finnigan, Renee Lamprecht, Brock Barry, Tamara et al.

Source: Journal of Medical Imaging & Radiation Oncology. Feb2016, Vol. 60 Issue 1, p112-118. 7p.

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan.

Authors: Lo, Serigne N. Hong, Angela M. Haydu, Lauren E. et al.

Source: Trials. 8/5/2019, Vol. 20 Issue 1, pN.PAG-N.PAG. 1p. 1 Diagram, 2 Charts.

Eligibility audits for the randomized neuropathic bone pain trial (TROG 96.05).

Authors: Roos, De Roos, Daniel E Davis, Sidney R et al.

Source: Australasian Radiology. Aug2000, Vol. 44 Issue 3, p303-307. 5p.